RAFA OTC
Rafarma Pharmaceuticals, Inc.
1W: -13.5%
1M: +6.7%
3M: +60.0%
YTD: +17.0%
1Y: -33.3%
3Y: -86.1%
5Y: -97.4%
$0.03
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$9M
Revenue
-66.0% YoY
$0M
Net Income
-68.7% YoY
$-1M
Free Cash Flow
+95.4% YoY
42.8%
Gross Margin
29.5%
Op. Margin
26.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE2.9%
ROA2.5%
ROIC3.4%
Valuation
P/E13.9
P/B0.3
EV/EBITDA28.8
Leverage
Debt/Equity0.00
Current Ratio1.13
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z5.15
Beneish M-2.40